Evotec AG (NASDAQ:EVTCY)

PRESS RELEASE

published on 02/07/2024 at 07:30, 2 years 8 months ago

Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials

Evotec SE ABL Broadly Neutralising Antibodies HIV NIAID
PRESS RELEASE

published on 01/22/2024 at 07:30, 2 years 9 months ago

Evotec SE: Invitation to Conference Call
Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links.

Conference Call Business Update Evotec SE Corporate Governance Market Developments
PRESS RELEASE

published on 11/08/2023 at 07:00, 2 years 11 months ago

Evotec SE reports results for the first nine months 2023 and provides corporate update
PRESS RELEASE

published on 11/07/2023 at 07:30, 2 years 11 months ago

Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
PRESS RELEASE

published on 11/01/2023 at 12:05, 3 years ago

Evotec SE to announce results for the first nine months 2023 on 08 November 2023
PRESS RELEASE

published on 10/05/2023 at 07:30, 3 years ago

Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
PRESS RELEASE

published on 09/27/2023 at 07:30, 3 years 1 month ago

Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
PRESS RELEASE

published on 09/26/2023 at 13:35, 3 years 1 month ago

Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
PRESS RELEASE

published on 08/29/2023 at 07:00, 3 years 2 months ago

Evotec SE reports results for the first half-year 2023 and provides corporate updates
PRESS RELEASE

published on 08/22/2023 at 14:00, 3 years 2 months ago

Evotec SE reports first half-year 2023 results on 29 August 2023

Published on 10/30/2026 at 23:35, 1 day 21 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 22 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 2 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 6 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/01/2026 at 10:35, 10 hours 58 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 16 hours 33 minutes ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 4 hours ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 22 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 22:30, 1 day 23 hours ago

/C O R R E C T I O N - OCI Global/

View all EQS

Published on 10/30/2026 at 23:00, 1 day 22 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 3 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 9 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 12 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News